Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(7;12)(q22;q24) CAMKK2/PRKRIP1

Written08-2018Jean-Loup Huret, Philippe Dessen

(Note : for Links provided by Atlas : click)

Identity

Atlas_Id 107414
Phylum Male organs: Prostate::
Note Non-annotated chromosomal abnormality. Preliminary data :
if you are an author who wish to write a full paper/card on this translocation, go to  How to contribute

Clinics and Pathology

Disease Prostate: Adenocarcinoma

Genes involved and Proteins

Gene NameCAMKK2
Location 12q24.31

Gene NamePRKRIP1
Location 7q22.1

Bibliography

From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
Lapuk AV, Wu C, Wyatt AW, McPherson A, McConeghy BJ, Brahmbhatt S, Mo F, Zoubeidi A, Anderson S, Bell RH, Haegert A, Shukin R, Wang Y, Fazli L, Hurtado-Coll A, Jones EC, Hach F, Hormozdiari F, Hajirasouliha I, Boutros PC, Bristow RG, Zhao Y, Marra MA, Fanjul A, Maher CA, Chinnaiyan AM, Rubin MA, Beltran H, Sahinalp SC, Gleave ME, Volik SV, Collins CC
J Pathol 2012 Jul;227(3):286-97
PMID 22553170
 


Translocations implicated (Data extracted from papers in the Atlas)

 t(7;12)(q22;q24) CAMKK2/PRKRIP1

External links

Mitelman database t(7;12)(q22;q24) [CaseList]     t(7;12)(q22;q24) [Transloc - MCList]   CAMKK2/PRKRIP1 Fusion - MCList]
COSMIC[ CAMKK2 ]   [ PRKRIP1 ]
arrayMap arrayMap ((UZH-SIB Zurich)   [auto + random 100 samples .. if exist ]   [tabulated segments]
 
 
Disease databaset(7;12)(q22;q24) CAMKK2/PRKRIP1
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Fri Oct 5 17:25:36 CEST 2018


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.